Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1143710]
Researchers:
Prof Andrew Scott
(Principal investigator)
,
A/Pr Hui Gan
,
A/Pr Paul Donnelly
,
A/Pr Uwe Ackermann
,
Dr Graeme O'Keefe
View all 7 related researchers
Brief description Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.
Funding Amount $AUD 725,015.07
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1143710
- PURL : https://purl.org/au-research/grants/nhmrc/1143710